{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:29:24Z","timestamp":1788607764388,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ANZ Journal of Surgery"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytoreductive surgery (CRS) with hyperthermic intraperitoneal early chemotherapy has gained acceptance as the standard of care for peritoneal surface malignancy over the past decade. This study reports the results of the first 6\u2009years of activity of the Western Australian Peritonectomy Service to compare outcomes of a low\u2010volume centre with world standards.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An audit of all patients who received CRS\u2009\u00b1\u2009hyperthermic intraperitoneal early chemotherapy treatment at the Western Australian Peritonectomy Service in its first 6\u2009years of operation was performed and results were compared to the recent world literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 130 patients were treated with 150 CRS procedures, including 50 pseudomyxoma peritonei (PMP), 53 colorectal cancers (CRCs), 27 appendix adenocarcinomas (AAs) and 20 other cancers. The median operating time was 12\u2009h with median length of hospital stay of 15\u2009days. Perioperative mortality was 0.67% and Clavien\u2010Dindo III\/IV morbidity was 20%. The mean packed red cell transfusion requirement was 0.34\u2009units\/case. Post\u2010discharge readmission rate was 25% and the return to theatre rate was 13%. The 4\u2010year overall survival rates for PMP, CRC and AA were 97%, 49% and 81%, respectively. The 3\u2010year disease\u2010free survival rates for PMP, CRC and AA were 74%, 26% and 36%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A CRS centre averaging 25 cases per year can achieve strong outcomes in line with high\u2010volume world centres.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ans.16627","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T07:38:14Z","timestamp":1613461094000},"page":"885-889","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Western Australian Peritonectomy Service: a review of the first 6\u2009years of operation of a low\u2010volume peritonectomy centre"],"prefix":"10.1111","volume":"91","author":[{"given":"Phillip","family":"McEntee","sequence":"first","affiliation":[{"name":"Department of General Surgery Joondalup Health Campus  Joondalup Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-9746","authenticated-orcid":false,"given":"Simon","family":"Keelan","sequence":"additional","affiliation":[{"name":"Department of General Surgery Joondalup Health Campus  Joondalup Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Salama","sequence":"additional","affiliation":[{"name":"Department of General Surgery Joondalup Health Campus  Joondalup Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moroz","sequence":"additional","affiliation":[{"name":"Western Australian Peritonectomy Service Joondalup Health Campus  Joondalup Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199501000-00004"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1247-5_23"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9182-x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0487-4"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ans.13280"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.80"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24746"},{"key":"e_1_2_9_11_1","first-page":"30","article-title":"Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery","volume":"4","author":"Saxana A","year":"2013","journal-title":"J. Gastrointest. Oncol."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.187"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2008.04.002"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0484-7"},{"key":"e_1_2_9_15_1","unstructured":"National Blood Authority Australia.Patient blood management guidelines.2012. [Cited Apr 2019.] Available from URL: https:\/\/www.blood.gov.au"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31662-5"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1564431"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.023"},{"key":"e_1_2_9_19_1","first-page":"18","article-title":"A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"52","author":"Lanuke K","year":"2009","journal-title":"Can. J. Surg."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.01.016"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-015-0478-9"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17497"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181d9765d"}],"container-title":["ANZ Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ans.16627","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ans.16627","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ans.16627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:30:06Z","timestamp":1693240206000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ans.16627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1111\/ans.16627"],"URL":"https:\/\/doi.org\/10.1111\/ans.16627","archive":["Portico"],"relation":{},"ISSN":["1445-1433","1445-2197"],"issn-type":[{"value":"1445-1433","type":"print"},{"value":"1445-2197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"2019-11-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}